Compound ID | 585
PGE 1818689
Class: Beta-lactam; quinolone
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Additionally DNA synthesis inhibitor ; Gyrase inhibitor |
| Target Pathogen: | Active against Escherichia coli and Staphylococcus aureus |
| Description: | Mallalieu NI, Bierman JC, Dorsey JS, et al. Pharmacokinetics and in vivo efficacy of quinolonyl-carbacephem antibacterials in animals. 38th-Intersci-Conf-Antimicrobial-Agents-Chemother 1998; 281. |
| Institute where first reported: | Procter Gamble Pharmaceuticals, Ireland |
| Year first mentioned: | 1998 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.